Nine in 10 Voters Express Concern That Medicare Lab Payment Cuts Will Harm Patient Access to Diagnostic Lab Testing, Finds National Survey from Quest Diagnostics
Article excerpt
Highlighted: the sentence this signal was extracted from
75% of registered voters surveyed call diagnostic testing "very important" to their care, and a bipartisan majority wants Congress to pass the RESULTS Act before additional Medicare cuts are scheduled to take effect January 2027 SECAUCUS, N.J., Sept. 16, 2026 /PRNewswire/ -- A new national survey finds the overwhelming majority of American voters rely on diagnostic laboratory testing to guide their healthcare decisions and are deeply concerned about scheduled Medicare payment cuts that could put that access at risk. The survey of 1,024 registered voters found that 83% relied on a diagnostic lab test in the past two years to help a doctor make a medical decision, and 96% consider these tests important to their own or their family's care with 75% saying they are "very important." Yet, about half (50%) say Medicare seniors, rural communities, and people managing cancer or other chronic diseases will all be hurt most if cuts take effect. Quest Diagnostics (NYSE: DGX ), one of the nation's leading providers of diagnostic information services, commissioned the survey and is providing a report of the findings: Left Out, Left Behind: Who's Harmed by Medicare Lab Payment Cuts? Concern intensifies sharply once voters learn how Medicare laboratory payment rates have previously been set. The Protecting Access to Medicare Act (PAMA), which passed into law in 2014, was meant to establish...
Keep reading with a free account
The rest of this article, and every signal for Quest Diagnostics, is in your free account.